Facebook
Twitter
LinkedIn
Forward
0605_SHSO_Pharmacy Grand Rounds - Urine Trouble: The Toxic Truth_Live
Overview
Description:
Several providers have raised concerns about the challenges of interpreting urine drug screen results. To address this issue, educational initiatives can improve understanding of how to interpret drug screen results and recognize their limitations. This will encourage a more supportive, nonjudgmental approach to urine drug screening, ultimately enhancing patient trust and engagement.
Target Audience
Pharmacists (PharmD)
Learning Objectives
After completing this activity, learners will be able to:
1. Differentiate sensitivity and specificity in the context of drug screening
2. Interpret false positive and false negative in common drug screen substances
3. Explain the pharmacokinetics of common substance and their metabolites
4. Correlate urine tox screen results with patient symptoms and clinical findings
Program
Assembly Bills 1195 & 241- Culturally Appropriate Care which is Free of Implicit Biases:
Peterson JA, Koelper NC, Curley C, Sonalkar SR, James AT. Reduction of racial disparities in urine drug testing after implementation of a standardized testing policy for pregnant patients. Am J Obstet Gynecol MFM. 2023;5(5):100913. doi:10.1016/j.ajogmf.2023.100913
Oh S, Hodges J, Salas-Wright C, Smith B, Goings TC. Ethnoracial differences in workplace drug testing and policies on positive drug tests in the United States. Drug Alcohol Depend. 2023;247:109898. doi:10.1016/j.drugalcdep.2023.109898
Faculty
Disclosure of Financial or In-Kind Commercial Support & Conflict of Interest
No one else involved in the planning or presentation of this educational activity have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. No financial or in-kind commercial support was received to produce or promote this educational activity.
– Provider Designee/Verification: Kerri Maya, PhD(c), MSL, RN, NPD-BC
Phipson Wu, PharmD, BCPS
Xinge Zheng, PharmD
Xinge Zheng, PharmD
Accreditation
Accreditation
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
Credit Designation Statement
Sutter Health designates this LIVE activity for a maximum of 1.00 knowledge-based contact hours for pharmacists. Learners should claim only the credit commensurate with the extent of their participation in the activity.
Attendance & Credit Claiming
Text the 6-letter attendance verification code to (916) 866-7913 to claim credit.
Available Credit
- 1.00 ACPE
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Sutter Health designates this Live activity for a maximum of 1.00 of ACPE credit(s). Credits for pharmacists and technicians will be transmitted to CPE Monitor and will be available within 60 days post-activity pending submission of individual NABP e-PID and DOB (mm/dd only). Learners should claim only the credit commensurate with the extent of their participation in the activity.
